🔗 Share this article

As the United States continues making historic revisions to its vaccine guidelines, one figure has emerged unexpectedly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and public health researcher who initially gained attention by casting doubt on Covid vaccinations throughout the global health crisis and has concentrated on alleged deaths after Covid immunization in her brief position at the FDA.

Planned Shifts to Childhood Immunization Program

Public health authorities were set to announce radical changes to the pediatric immunization program in December, aligning the US with Denmark’s vaccine program, according to reports – a substantial departure that would put the US at odds with a large portion of the world with no evidence for public health gain. The announcement has been delayed until the new year.

In place of the top vaccines chief, Tracy Beth Høeg is listed to speak at the gathering. She was just designated acting director of the FDA’s CDER, the fifth individual to run the center this year.

A New Direction at the Agency

This interim role could signify a strengthened alliance between the pharmaceutical and vaccine branches as Dr. Høeg and Prasad strengthen their influence at the agency – and it signals a increased emphasis upon dismantling already-approved vaccines at the FDA.

Høeg has frequently advocated for halting specific childhood immunization guidelines in the US to become more similar to Denmark, a nation with universal health coverage and a population approximately the population of the state of Wisconsin.

So far statements, she has kept her attention on vaccines – typically the domain of Prasad, head of the FDA’s vaccine center – instead of pharmaceutical oversight.

Questions Over Background

Høeg has no apparent experience in medication creation, approval processes or leadership, which has been typical for past leaders of the CBER. She has worked at the FDA as a top consultant to the agency head and the vaccine center since spring.

“She appears not to have the necessary background” for running the CDER, stated a neurologist and psychiatrist. “She has not conducted a clinical trial. She has no expertise in managing a major agency. She has no expertise in pharmaceutical oversight.”

Former heads of the center would “be deeply familiar with laws and regulations and the underlying principles of drug development”, said Dr. Janet Woodcock. “Objectively, she doesn’t have the sort of resume that former directors who headed CBER have had.”

The drug center has an immense range of responsibilities at the agency, Woodcock pointed out.

“Many people just focuses on the novel medication approvals, but the generic drug division clears thousands of generic drugs. There’s a biosimilars program, non-prescription drug unit and other areas, and each of these must be looked after,” Woodcock noted. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

There is also, a major leadership aspect to the job, which supervises over 5,000 personnel. “It’s a enormous administrative position, if you perform it correctly,” she said.

Response and Controversial Initiatives

Regarding concerns about Høeg’s qualifications and whether this assignment signifies more teamwork among FDA leaders on vaccines, a spokesperson said that the “concerns rely on incorrect presumptions”.

“This background is consistent with the responsibilities of her position,” the representative stated, noting the period Høeg spent advising the FDA commissioner on “pharmaceutical safety and approval science, including computerized risk analysis and immunization monitoring”.

In her interim role, Dr. Høeg assumes responsibility for the agency head's recently launched expedited review system, a disputed rapid drug-approval program that reportedly concerned her preceding directors. “By what process are these drugs being selected for this expedited pathway? Who is making the calls?” Dr. Howard questioned. “There’s a lot of confidentiality happening at the regulatory body right now.”

In general, he remarked, “the Food and Drug Administration looks to be trending towards less stringent regulations of most medications, aside from vaccines.”

Documented History on Vaccines

With vaccines, Dr. Høeg has a more established, if problematic, history, some experts observe. She published a study using unconfirmed crowd-sourced reports to estimate the rate of heart inflammation after Covid immunization. She counseled the state of Florida chief medical officer Joseph Ladapo, who reportedly have modified findings to suggest COVID-19 vaccinations are riskier than they are.

Part of her “wish list” for the incoming federal leadership included changing guidelines for novel immunizations and discontinuing “unnecessary” immunizations, she stated following the vote on a online show. At the agency, Høeg has allegedly suggested excluding teenage boys from receiving Covid vaccines.

“She is an thorough ideologue who begins with her beliefs and reverse-engineers to accommodate the data in a very deceptive, fraudulent way,” Howard said.

Gaining Influence and a “Push for Payback”

Dr. Høeg became part of fellow dissenters, {like|